SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-16-134983
Filing Date
2016-11-16
Accepted
2016-11-16 16:48:31
Documents
5
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A v452924_10ka.htm 10-K/A 122919
2 EXHIBIT 31.1 v452924_ex31-1.htm EX-31.1 9583
3 EXHIBIT 31.2 v452924_ex31-2.htm EX-31.2 9429
4 EXHIBIT 32.1 v452924_ex32-1.htm EX-32.1 4042
5 EXHIBIT 32.2 v452924_ex32-2.htm EX-32.2 4201
  Complete submission text file 0001144204-16-134983.txt   151436
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (908) 864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-31326 | Film No.: 162002936
SIC: 8731 Services-Commercial Physical & Biological Research